Atıf İçin Kopyala
Akbiyik F., Demirpence E., KUZU M. A., Kilinc K.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, cilt.57, sa.9, ss.631-636, 2001 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
57
Sayı:
9
-
Basım Tarihi:
2001
-
Doi Numarası:
10.1007/s002280100352
-
Dergi Adı:
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.631-636
-
Anahtar Kelimeler:
myeloperoxidase, 5-fluorouracil, myelosuppression, PHASE-II TRIAL, POLYMORPHONUCLEAR LEUKOCYTES, COLORECTAL-CANCER, FOLINIC ACID, CHEMOTHERAPY, NEUTROPHIL, FLUOROURACIL, RECRUITMENT, PEROXIDASE, LEUCOVORIN
-
Ankara Üniversitesi Adresli:
Evet
Özet
Objective: Myeloperoxidase (MPO) exists in neutrophils and has an important bactericidal role. During phagocytosis, MPO catalyzes a peroxidative reaction using chloride ion and hydrogen peroxide (H2O2) as substrate. The aim of the present study was to investigate whether 5-fluorouracil (5-FU), a chemotherapeutic agent, has a direct inhibitory effect on MPO and to evaluate some properties of this inhibition.